Search Results 61-70 of 17126 for ibs

  1. Use of antispasmodics for the treatment of abdominal pain - Mayo Clinic

    This highly prevalent category of GI disorders includes irritable bowel syndrome (IBS), functional dyspepsia (FD) and centrally mediated abdominal pain syndrome ...

  2. Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption - Mayo Clinic

    ... IBS-D with Bile Acid Malabsorption. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  3. Identifying diarrhea caused by bile acid malabsorption - Mayo Clinic

    Studies have demonstrated that BAM occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea (IBS ... IBS-D. A clinical ...

  4. Publications - Brian E. Lacy, M.D., Ph.D. - Mayo Clinic

    2020. Lacy BE. Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome. J Fam Pract. 2019 Oct; 68 (8):S43- ...

  5. The Role of Bile Acid Diarrhea in Adolescents with Irritable Bowel Syndrome - Mayo Clinic

    About this study. The purpose of this study is to measure 48 hour fecal bile acids in IBS-D adolescents and compare it to HC; measure serum C4 and FGF-19 in ...

  6. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric ...

  7. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome · Share · Facebook · Twitter.

  8. Linaclotide (oral route) - Mayo Clinic

    Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It works by increasing intestinal ...

  9. A Study of Eluxadoline in Participants with Irritable Bowel Syndrome with Diarrhea (IBS-D) Who Have Evidence of Bile Acid Malabsorption (BAM) - Mayo Clinic

    Eluxadoline has been approved by the FDA for people with IBS-D but it is not known whether it will work the same way in people with IBS-D who also have BAM.

  10. Overview - Gastrointestinal Barrier Function Laboratory - Mayo Clinic Research

    Mayo Clinic's Gastrointestinal Barrier Function Lab, led by Madhu Grover, M.B.B.S., advances the understanding of irritable bowel syndrome (IBS), ...